Delphi Diagnostics Appoints Harry Bushong to Board of Directors

Press Release Delphi Diagnostics Appoints Harry Bushong to Board of Directors A PDF of the release can be found here Seasoned venture capital leader brings deep expertise in life sciences and healthcare innovation Houston, TX, April 6, 2026 — Delphi Diagnostics today announced the appointment of Harry Bushong to its Board of Directors. A veteran […]

Data Presented at SABCS 2025 Demonstrated that the Endocrine Activity Index® (EAI®) May Identify Patients Most Likely to Benefit from Extended Endocrine Therapy

Press Release Data Presented at SABCS 2025 Demonstrated that the Endocrine Activity Index® (EAI®) May Identify Patients Most Likely to Benefit from Extended Endocrine Therapy A PDF of the release can be found here Houston, TX, February 16, 2026 — New data presented at the 2025 San Antonio Breast Cancer Symposium (SABCS) from the NRG/NSABP […]

Data Presented at SABCS 2025 Reinforce the Endocrine Activity Index® (EAI®) as a Powerful Tool to Inform Treatment Decisions in HR+/HER2- Breast Cancer

Press Release Data Presented at SABCS 2025 Reinforce the Endocrine Activity Index® (EAI®) as a Powerful Tool to Inform Treatment Decisions in HR+/HER2- Breast Cancer A PDF of the release can be found here Houston, TX, February 10, 2026 – Delphi Diagnostics today announced that clinical evidence presented at the 2025 San Antonio Breast Cancer […]

Delphi Diagnostics® Announces Four Abstracts and one General Session Presentation Featuring the Endocrine Activity IndexTM to be Presented at the San Antonio Breast Cancer Symposium

Press Release Delphi Diagnostics® Announces Four Abstracts and one General Session Presentation Featuring the Endocrine Activity Index® to be Presented at the San Antonio Breast Cancer Symposium A PDF of the release can be found here Houston, TX, November 4, 2025 – Delphi Diagnostics announces the upcoming presentation of four scientific abstracts, including one platform […]